Hepion Pharmaceuticals Inc

NASDAQ HEPA

Data sourced from iex and EODHD
Download Data

Hepion Pharmaceuticals Inc Income Statement 2013 - 2024

This table shows the Income Statement for Hepion Pharmaceuticals Inc going from 2013 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - -
Cost of Revenue
M 0 - 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit
M 0 - 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Expenses
M 11 - 11 14 10 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 2 2 2 2 0 0 3 4 2 2 3 3 3 2 2 2 1 1 1 1 1 2 2 2 2 1 2 2 2 2 2 2 1 1 1 2 2 1 1 1 0 0 0
Research and Development (R&D) Expenses
M 5 5 9 12 8 8 6 16 7 7 6 4 3 3 4 3 1 1 1 1 1 1 2 2 2 3 4 3 3 4 3 4 3 4 4 4 3 2 0 0 0 0 0
Other Operating Expenses
M 3 - 0 0 2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Costs and Expenses
M 7 - 11 14 8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income
M -10 -7 -11 -14 -10 -8 -8 -20 -9 -9 -9 -7 -6 -5 -6 -5 -2 -2 -2 -2 -2 -3 -4 -4 -4 -5 -6 -5 -5 -6 -5 -6 -5 -6 -5 -5 -4 -3 -1 -1 0 0 0
Interest Expense
M 0 - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 1 1 0 7 3 - 0 1 1 2 - - - - 0 5 9 0 0
Non-operating Income/Expense
M -4 -4 0 0 -2 -2 0 0 -1 -1 -1 -1 0 0 0 0 0 0 0 0 0 0 4 0 1 -1 0 7 -3 0 0 1 1 2 - - -3 -5 0 5 -9 0 0
EBT
M -11 -11 -11 -14 -10 -10 -9 -20 -10 -10 -9 -8 -6 -5 -6 -5 -2 -2 -2 -2 -2 -3 0 -4 -3 -4 -6 2 -8 -6 -5 -5 -4 -3 -5 -5 -4 -3 -1 4 -9 0 0
Income Tax Provision
M 0 - 0 0 -3 -3 0 0 1 - 1 1 0 0 0 0 0 0 0 -1 0 0 -4 0 -1 -2 0 -7 3 -2 0 -1 -1 -2 - - -3 -5 0 -5 9 0 0
Income after Tax
M -11 - -10 -14 -7 -7 -9 -20 -10 - -10 -8 -6 -5 -6 -5 -2 -2 -2 -1 -2 -2 4 -4 -3 -1 -6 9 -10 -5 -5 -5 -3 -1 - - -1 2 -2 10 -18 0 0
Non-Controlling Interest
M - - - 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 9 0 - - - - - - - - - - - - - - - - - - -
Net Income
M - - - -14 -13 -10 -9 -20 -7 -10 -9 -8 -6 -5 -6 -5 -4 -2 -2 -6 -2 -2 -9 -4 - - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 4,564,316.00 4,818,733.00 3,838,289.00 3,826,505.00 3,811,480.00 76,229,617.00 76,229,617.00 76,229,617.00 -0.47 76,225,254.00 76,225,249.00 3,811,262.00 2,608,037.00 52,160,742.00 451,256.00 424,725.00 4,345,699.00 4,345,699.00 172,681.00 42,991.00 12,506.00 202,455.00 10,122.00 7,617.00 7,231.00 140,000.00 6,837.00 136,750.00 5,652.00 5,362.00 3,385.00 67,714.00 2,437.00 2,378.00 1,990.00 39,803.00 1,988.00 1,988.00 1,804.00 36,092.00 1,315.00 1,649.00 1,649.00
EBITDA
M -7 - -11 -14 -8 -10 -8 -20 -9 -10 -8 -7 -6 -5 -6 -5 -2 -2 -2 -2 -2 -4 -8 -4 -4 -5 -6 -12 -2 -6 -5 -6 -5 -8 -5 -5 -4 -3 -1 -6 8 0 0
Depreciation and Amortization
M 0 - 0 0 0 - 0 0 0 - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 -9 0 0
EBIT
M -7 - -11 -14 -8 -8 -8 -20 -9 -9 -9 -7 -6 -5 -6 -5 -2 -2 -2 -2 -2 -4 -8 -4 -4 -5 -6 -12 -2 -6 -5 -6 -5 -8 -5 -5 -4 -3 -1 -11 17 0 0
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 3.57 - 1.31 -0.02 29.74 29.74 -0.96 0.44 -7.51 - -8.06 -10.57 -0.43 0.06 0.99 -1.97 12.32 12.32 4.99 48.49 -3.13 16.44 2,352.94 -3.59 16.61 63.86 1.11 -354.46 -35.58 29.75 1.25 11.29 18.77 81.96 - - 68.22 156.06 -26.38 -119.85 -95.07 -2.90 -0.94
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% 88.82 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income Margin
% -9,485.64 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% -6,403.29 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBIT Ratio
% -6,414.47 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBT Ratio
% -10,451.70 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email